Patients with coccidioidal meningitis require lifelong antifungal therapy. Cumulative toxicity and lack of antifungal efficacy require salvage therapy in the treatment of some patients. In a retrospective review of nine patients with coccidioidal meningitis treated with isavuconazole, successful therapy was seen in three patients and stable disease was confirmed in six patients. Isavuconazole may be a useful addition to the therapeutic choices currently available for coccidioidal meningitis.
CITATION STYLE
Heidari, A., Quinlan, M., Benjamin, D. J., Laurence, B., Mu, A., Ngai, T., … Thompson, G. R. (2019). Isavuconazole in the treatment of coccidioidal meningitis. Antimicrobial Agents and Chemotherapy, 63(3). https://doi.org/10.1128/AAC.02232-18
Mendeley helps you to discover research relevant for your work.